Alfred Lee, MD, PhD
Professor of Medicine (Hematology); Director, Hematology/Oncology Fellowship Program; Chief, Classical Hematology Program
Research & Publications
Biography
News
Coauthors
Selected Publications
- Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) RegistryPine A, Butt A, Garcia-Milian R, Gu S, Restrepo V, Chock Y, Hwa J, Tormey C, Rinder H, Goshua G, Belmont H, Bertolaccini M, Branch D, Erhan D, Kello N, Knight J, Petri M, Willis R, Lee A, Sharda A. Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry. Blood 2023, 142: 2575. DOI: 10.1182/blood-2023-185232.
- Evaluating Inpatient Care Team Models in Hematology and Oncology Fellowship Programs in the United StatesStempel J, Li A, Pine A, Restrepo V, Bewersdorf J, Stahl M, Podoltsev N, Mendez L, Shallis R, Rangachari D, Lee A, Michaelis L, Zeidan A. Evaluating Inpatient Care Team Models in Hematology and Oncology Fellowship Programs in the United States. Blood 2023, 142: 2319. DOI: 10.1182/blood-2023-187163.
- P1637: PROTEOMIC PROFILING OF DIFFERENT ANTIPHOSPHOLIPID ANTIBODY‐POSITIVE PHENOTYPES: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) REGISTRYButt A, Garcia‐Milian R, Goshua G, Gu S, Hwa J, Chun H, Belmont H, Kello N, Branch D, Petri M, Knight J, Willis R, Bertolaccini M, Erkan D, Lee A, Sharda A, Pine A. P1637: PROTEOMIC PROFILING OF DIFFERENT ANTIPHOSPHOLIPID ANTIBODY‐POSITIVE PHENOTYPES: RESULTS FROM ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND INTERNATIONAL NETWORKING (APS ACTION) REGISTRY. HemaSphere 2023, 7: e160607f. PMCID: PMC10429839, DOI: 10.1097/01.hs9.0000973420.16060.7f.
- Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider supportLee A, Masselink LE, De Castro LM, Marshall AL, Connell NT, Dent GA, Fritz J, Homer M, Lucas TL, Naik RP, Nelson M, O’Connell C, Rajasekhar A, Reynolds R, Sharma D, Smith M, Weeks LD, Erikson CE. Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support. Blood Advances 2023, 7: 3058-3068. PMID: 35476017, PMCID: PMC10331414, DOI: 10.1182/bloodadvances.2021006140.
- Diversity, equity, and inclusion (DEI) and health equity (HE) education in hematology/oncology (HO) fellowship: A longitudinal curriculum.Ansari N, Fanucci K, Burtness B, Goldberg S, Hurwitz M, Podoltsev N, Lee A, Kunz P. Diversity, equity, and inclusion (DEI) and health equity (HE) education in hematology/oncology (HO) fellowship: A longitudinal curriculum. Journal Of Clinical Oncology 2023, 41: 11002-11002. DOI: 10.1200/jco.2023.41.16_suppl.11002.
- A multifaceted approach to wellness in a hematology/oncology fellowship program.Srikumar T, Ansari N, Fanucci K, Goldberg S, Hurwitz M, Podoltsev N, Lee A, Sanft T. A multifaceted approach to wellness in a hematology/oncology fellowship program. Journal Of Clinical Oncology 2023, 41: 11006-11006. DOI: 10.1200/jco.2023.41.16_suppl.11006.
- Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic SyndromeAllen C, Gautam S, Cheng W, Pine A, Podoltsev N, Zeidan A, Lee A, Shallis R. Impact of Prophylactic Antibacterials on Coagulation Profiles and Bleeding in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome. Acta Haematologica 2023, 146: 287-292. PMID: 37166332, DOI: 10.1159/000530153.
- Summiting thrombotic hazards in gliomaGoshua G, Lee A. Summiting thrombotic hazards in glioma. Blood 2023, 141: 1245-1246. PMID: 36929442, DOI: 10.1182/blood.2022019020.
- Thrombosis questions from the inpatient wardsGoshua G, Bendapudi P, Lee A. Thrombosis questions from the inpatient wards. Hematology 2022, 2022: 481-490. PMID: 36485139, PMCID: PMC9819989, DOI: 10.1182/hematology.2022000384.
- Plasma Proteomic Profiling Illustrates Endothelial and Complement Signature in Patients with Alcohol-Associated CirrhosisAllen C, Butt A, Zhao X, Li F, Bahel P, Chang C, Chun H, Gu S, Hwa J, Jakab S, Chen B, Garcia-Tsao G, Rinder H, To U, McConnell M, Lee A, Pine A. Plasma Proteomic Profiling Illustrates Endothelial and Complement Signature in Patients with Alcohol-Associated Cirrhosis. Blood 2022, 140: 8382-8383. DOI: 10.1182/blood-2022-162633.
- Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene VicleucelMirza A, Pine A, Rasheed Y, Hamouche R, Leveille E, Goshua G, Gu S, Liu Y, VanOudenhove J, Bar N, Neparidze N, Foss F, Gowda L, Isufi I, Halene S, Lee A, Seropian S. Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene Vicleucel. Blood 2022, 140: 10410-10412. DOI: 10.1182/blood-2022-168374.
- Cost-Effectiveness of Caplacizumab without First-Line Therapeutic Plasma Exchange Vs. Standard-of-Care for Patients with Immune Thrombotic Thrombocytopenic Purpura: Setting Future Clinical Trial ThresholdsButt A, Lee A, Goshua G. Cost-Effectiveness of Caplacizumab without First-Line Therapeutic Plasma Exchange Vs. Standard-of-Care for Patients with Immune Thrombotic Thrombocytopenic Purpura: Setting Future Clinical Trial Thresholds. Blood 2022, 140: 1621-1622. DOI: 10.1182/blood-2022-170003.
- Improving Diversity, Equity, and Inclusion Education in Hematology/Oncology TrainingKress A, Lu B, Butt A, Christian J, Podoltsev N, Hurwitz M, Goldberg S, Burtness B, Isufi I, Latimore D, Lee A, Kunz P. Improving Diversity, Equity, and Inclusion Education in Hematology/Oncology Training. Blood 2022, 140: 5029-5030. DOI: 10.1182/blood-2022-170950.
- Monogenic and Polygenic Contributions to Venous Thromboembolism (VTE) and Splanchnic Thrombosis in Patients (pts) with Pancreatic Cancer (PC)Nassar A, Groha S, El-am E, Bejjani A, Zarif T, Mouhieddine T, Alaiwi S, Adib E, Ng K, Connors J, Lee A, Gusev A. Monogenic and Polygenic Contributions to Venous Thromboembolism (VTE) and Splanchnic Thrombosis in Patients (pts) with Pancreatic Cancer (PC). Blood 2022, 140: 5525-5526. DOI: 10.1182/blood-2022-163804.
- Bias Against International Medical Graduates in the Hematology/Oncology Fellowship Recruitment Process: Findings From a Nationwide Survey of Fellowship Program DirectorsButt A, Mankbadi M, Erikson C, Marshall A, Masselink LE, Tong G, Hafler J, Podoltsev N, Lee AI. Bias Against International Medical Graduates in the Hematology/Oncology Fellowship Recruitment Process: Findings From a Nationwide Survey of Fellowship Program Directors. JCO Oncology Practice 2022, 18: 783-787. PMID: 36108253, DOI: 10.1200/op.22.00219.
- COVID-19 and antiphospholipid antibodiesButt A, Erkan D, Lee A. COVID-19 and antiphospholipid antibodies. Best Practice & Research Clinical Haematology 2022, 35: 101402. PMID: 36494152, PMCID: PMC9568270, DOI: 10.1016/j.beha.2022.101402.
- The Incidence and Significance of Iliac Vein Stenosis in Patients With Deep Vein ThrombosisAli S, Chan S, Brahmandam A, Xu Y, Deng Y, Elbadawy A, Lee A, Chaar C. The Incidence and Significance of Iliac Vein Stenosis in Patients With Deep Vein Thrombosis. Journal Of Vascular Surgery 2022, 76: e32-e33. DOI: 10.1016/j.jvs.2022.06.059.
- Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluationStempel JM, Podoltsev NA, Zeidan AM, Lee AI, Shallis RM. Concealed by the convenient: acquired von Willebrand syndrome in myeloproliferative neoplasm requires a thorough evaluation. Annals Of Hematology 2022, 101: 2559-2561. PMID: 35984499, DOI: 10.1007/s00277-022-04943-3.
- Association of iron infusion reactions with ABO blood typeButt A, Muradashvili T, Soliman S, Li F, Burns AJ, Brooks A, Browning S, Bar N, Borgman G, Goshua G, Hwa J, Martin K, Rinder H, Tormey C, Pine AB, Bona RD, Lee AI, Neparidze N. Association of iron infusion reactions with ABO blood type. European Journal Of Haematology 2022, 109: 519-525. PMID: 35871468, DOI: 10.1111/ejh.13838.
- The case for classical haematology: the impact of a name and the future of a fieldAl-Samkari H, Loren AW, Lee AI. The case for classical haematology: the impact of a name and the future of a field. The Lancet Haematology 2022, 9: e455-e459. PMID: 35500590, DOI: 10.1016/s2352-3026(22)00096-5.
- A guide to molecular and functional investigations of platelets to bridge basic and clinical sciencesTyagi T, Jain K, Gu S, Qiu M, Gu V, Melchinger H, Rinder H, Martin K, Gardiner E, Lee A, Tang W, Hwa J. A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. Nature Cardiovascular Research 2022, 1: 223-237. PMID: 37502132, PMCID: PMC10373053, DOI: 10.1038/s44161-022-00021-z.
- Iron Infusion Reactions: Risk Factors and Real-World ExperienceButt A, Muradashvili T, Soliman S, Goshua G, Burns A, Bar N, Martin K, Borgman G, Bona R, Lee A, Neparidze N. Iron Infusion Reactions: Risk Factors and Real-World Experience. Blood 2021, 138: 4154. DOI: 10.1182/blood-2021-151048.
- Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune ThrombocytopeniaGoshua G, Sinha P, Pischel L, Lee A, Cuker A. Cost-Effectiveness of Second-Line Therapies in Adult Patients with Chronic Immune Thrombocytopenia. Blood 2021, 138: 751. DOI: 10.1182/blood-2021-144819.
- Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune ThrombocytopeniaLee E, Moreira M, Al-Samkari H, Cuker A, DiRaimo J, Gernsheimer T, Kruse A, Kessler C, Kruse C, Leavitt A, Lee A, Liebman H, Newland A, Ray A, Tarantino M, Thachil J, Kuter D, Cines D, Bussel J. Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia. Blood 2021, 138: 586. PMCID: PMC8701617, DOI: 10.1182/blood-2021-152918.
- Diversity, Equity, and Inclusion in Hematology and Oncology Fellowship ProgramsMankbadi M, Alemu L, Bey A, Connell N, Fanning L, Frustace P, Genao I, Hafler J, LaCasce A, Lucas T, Marshall A, Mones J, Murphy M, Naik R, Podoltsev N, Lee A. Diversity, Equity, and Inclusion in Hematology and Oncology Fellowship Programs. Blood 2021, 138: 2977. DOI: 10.1182/blood-2021-145827.
- Implementing a Full Time Equivalent-Supported Hematology/Oncology Fellowship Core Faculty Program May Improve Faculty Engagement in Education, Mentorship, and RecruitmentChristian J, Gilkes L, Goldberg S, Hurwitz M, Podoltsev N, Lee A. Implementing a Full Time Equivalent-Supported Hematology/Oncology Fellowship Core Faculty Program May Improve Faculty Engagement in Education, Mentorship, and Recruitment. Blood 2021, 138: 2974. DOI: 10.1182/blood-2021-154326.
- Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 ThrombosisMadeeva D, Borges K, Shallow M, Juthani P, Wang S, Gupta A, Chun H, Lee A, Pine A. Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis. Blood 2021, 138: 777. PMCID: PMC8701622, DOI: 10.1182/blood-2021-153959.
- Cerebral venous sinus thrombosis after vaccination: the UK experienceLee EJ, Lee AI. Cerebral venous sinus thrombosis after vaccination: the UK experience. The Lancet 2021, 398: 1107-1109. PMID: 34370974, PMCID: PMC8346246, DOI: 10.1016/s0140-6736(21)01788-8.
- A Brewing Back PainPischel L, Geirsson A, Magaldi J, Martinello RA, Lee AI. A Brewing Back Pain. New England Journal Of Medicine 2021, 385: 66-72. PMID: 34192434, PMCID: PMC9273048, DOI: 10.1056/nejmcps2034802.
- Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathyMcConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, Bonaffini PA, Sironi S, Alessio MG, Previtali G, Seghezzi M, Zhang X, Lee A, Pine AB, Chun HJ, Zhang X, Fernandez-Hernando C, Qing H, Wang A, Price C, Sun Z, Utsumi T, Hwa J, Strazzabosco M, Iwakiri Y. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. Journal Of Hepatology 2021, 75: 647-658. PMID: 33991637, PMCID: PMC8285256, DOI: 10.1016/j.jhep.2021.04.050.
- PRO-THROMBOTIC SIGNATURE FROM NEUTROPHIL ACTIVATION AND DECREASED ADAMTS13 TO VWF RATIO IS A KEY DRIVER OF CARDIAC INJURY IN HOSPITALIZED PATIENTS WITH COVID-19Wang S, Pine A, Mankbadi M, Chang C, Madeeva D, Zhang H, Dajani A, Crandall I, Sugeng L, Lee A, Chun H. PRO-THROMBOTIC SIGNATURE FROM NEUTROPHIL ACTIVATION AND DECREASED ADAMTS13 TO VWF RATIO IS A KEY DRIVER OF CARDIAC INJURY IN HOSPITALIZED PATIENTS WITH COVID-19. Journal Of The American College Of Cardiology 2021, 77: 3193. PMID: 34167644, PMCID: PMC8091195, DOI: 10.1016/s0735-1097(21)04548-4.
- Endovascular Treatment of Renal Vein Thrombosis in a Young Patient With Lung TransplantBrahmandam A, Lee A, Chaar C. Endovascular Treatment of Renal Vein Thrombosis in a Young Patient With Lung Transplant. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2021, 9: 542-543. DOI: 10.1016/j.jvsv.2020.12.022.
- Sex Differences in Long-Term Outcomes of Patients with Deep Vein ThrombosisBrahmandam A, Chan S, Aspegren-Valcarce M, Zhuo H, Zhang Y, Tonnessen B, Lee A, Chaar C. Sex Differences in Long-Term Outcomes of Patients with Deep Vein Thrombosis. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2021, 9: 546-547. DOI: 10.1016/j.jvsv.2020.12.033.
- Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraGoshua G, Sinha P, Hendrickson J, Tormey C, Bendapudi PK, Lee AI. Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood 2021, 137: 969-976. PMID: 33280030, PMCID: PMC7918179, DOI: 10.1182/blood.2020006052.
- Clinical Characteristics and Outcomes of Splenic Infarction in Cancer Patients - a Retrospective, Single Center Report of 206 CasesBewersdorf J, Parmar N, Gettinger S, Israel G, Lee A. Clinical Characteristics and Outcomes of Splenic Infarction in Cancer Patients - a Retrospective, Single Center Report of 206 Cases. Blood 2020, 136: 22-23. DOI: 10.1182/blood-2020-136646.
- Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative AssessmentDurani U, Manana A, May J, Nelson M, Zheng Z, Gollapudi A, Alam S, Reynolds R, Thompson J, Kumbamu A, Das D, Murphy M, Henry E, Lee A, Marshall A, Wun T, Weeks L. Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment. Blood 2020, 136: 20-21. PMCID: PMC8330314, DOI: 10.1182/blood-2020-143347.
- The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director PerspectivesManana A, Durani U, Reynolds R, Kumbamu A, Das D, Murphy M, Henry E, Lee A, Marshall A. The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives. Blood 2020, 136: 24-25. PMCID: PMC8544190, DOI: 10.1182/blood-2020-141514.
- Factors Associated with Burnout Among Hematology & Oncology PhysiciansMasselink L, Lee A, Erikson C. Factors Associated with Burnout Among Hematology & Oncology Physicians. Blood 2020, 136: 41-42. DOI: 10.1182/blood-2020-139798.
- Advanced Imaging and Targeted Myeloma Lesion Biopsies to Enhance Global Response Assessment and Evaluate Spatial Heterogeneity in Multiple MyelomaBrowning S, Parker T, Bar N, Anderson T, Dhodapkar M, Seropian S, Lee A, Prebet T, Halene S, Xu M, Gorshein E, Talsania A, Kidwai W, Witt D, Chang V, Lischuk A, Wei W, Haims A, Neparidze N. Advanced Imaging and Targeted Myeloma Lesion Biopsies to Enhance Global Response Assessment and Evaluate Spatial Heterogeneity in Multiple Myeloma. Blood 2020, 136: 20-22. DOI: 10.1182/blood-2020-136478.
- Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic PurpuraGoshua G, Sinha P, Hendrickson J, Tormey C, Bendapudi P, Lee A. Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura. Blood 2020, 136: 18-19. DOI: 10.1182/blood-2020-138515.
- VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional StudyMadeeva D, Christian J, Goshua G, Chun H, Lee A, Pine A. VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study. Blood 2020, 136: 34-35. PMCID: PMC8330245, DOI: 10.1182/blood-2020-142917.
- Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched AnalysisGoshua G, Liu Y, Meizlish M, Fine R, Amin K, Chang E, Liu Y, McManus D, Petrosan A, Chaar C, Chun H, Defilippo N, Neuberg D, Owusu K, Lee A. Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis. Blood 2020, 136: 23-24. PMCID: PMC8330288, DOI: 10.1182/blood-2020-143349.
- Cryptic CachexiaOdio CD, O'Brien CR, Jacox J, Jain D, Lee AI. Cryptic Cachexia. New England Journal Of Medicine 2020, 383: 68-74. PMID: 32609985, DOI: 10.1056/nejmcps1817531.
- Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional studyGoshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. The Lancet Haematology 2020, 7: e575-e582. PMID: 32619411, PMCID: PMC7326446, DOI: 10.1016/s2352-3026(20)30216-7.
- A novel approach to the program evaluation committeeSchwartz AR, Siegel MD, Lee AI. A novel approach to the program evaluation committee. BMC Medical Education 2019, 19: 465. PMID: 31842868, PMCID: PMC6916454, DOI: 10.1186/s12909-019-1899-x.
- The next(gen) step in coagulation testingLee AI, Connors JM. The next(gen) step in coagulation testing. Blood 2019, 134: 2002-2003. PMID: 31805193, DOI: 10.1182/blood.2019001414.
- Trends and factors affecting the US adult hematology workforce: a mixed methods studySharma D, Wallace N, Levinsohn EA, Marshall AL, Kayoumi K, Madero J, Homer M, Reynolds R, Hafler J, Podoltsev NA, Lee AI. Trends and factors affecting the US adult hematology workforce: a mixed methods study. Blood Advances 2019, 3: 3550-3561. PMID: 31738829, PMCID: PMC6880914, DOI: 10.1182/bloodadvances.2019000307.
- Perceptions and Attitudes Toward Single-Board Hematology Training in the United States: A Program Director SurveyNaik R, Montana M, Kersun L, Nagalla S, Lee A. Perceptions and Attitudes Toward Single-Board Hematology Training in the United States: A Program Director Survey. Blood 2019, 134: 3392. DOI: 10.1182/blood-2019-126310.
- Hematology/Oncology Fellows' Future Plans and Job Expectations: Findings from the 2019 Hematology/Oncology Fellows SurveyMasselink L, Lee A, Erikson C. Hematology/Oncology Fellows' Future Plans and Job Expectations: Findings from the 2019 Hematology/Oncology Fellows Survey. Blood 2019, 134: 5780. DOI: 10.1182/blood-2019-126899.
- Mentorship Experiences Among Second-Year U.S. Hematology/Oncology Fellows in the 2019 ASH Hematology/Oncology Fellows SurveyLee A, Masselink L, Bass E, Connell N, Marshall A, Erikson C. Mentorship Experiences Among Second-Year U.S. Hematology/Oncology Fellows in the 2019 ASH Hematology/Oncology Fellows Survey. Blood 2019, 134: 2124. DOI: 10.1182/blood-2019-132252.
- Daratumumab in the Clinic, a Real-Word Experience at Yale Cancer CenterBrowning S, Parker T, Bar N, Seropian S, Lee A, Anderson T, Neparidze N. Daratumumab in the Clinic, a Real-Word Experience at Yale Cancer Center. Blood 2019, 134: 5569. DOI: 10.1182/blood-2019-130134.
- Providers Increased the Use of Direct Oral Anticoagulants in Patients with Cancer-Associated Thromboembolism without Gaining Complete Confidence: A Health System-Wide Retrospective Registry Study and a Providers' SurveyPine A, Lee A. Providers Increased the Use of Direct Oral Anticoagulants in Patients with Cancer-Associated Thromboembolism without Gaining Complete Confidence: A Health System-Wide Retrospective Registry Study and a Providers' Survey. Blood 2019, 134: 2097. DOI: 10.1182/blood-2019-130200.
- Associations between hematology/oncology fellows' training and mentorship experiences and hematology-only career plansMasselink LE, Erikson CE, Connell NT, De Castro LM, Dent GA, Marshall AL, Naik RP, Nelson M, O’Connell C, Rajasekhar A, Sharma D, Smith M, Lee AI. Associations between hematology/oncology fellows' training and mentorship experiences and hematology-only career plans. Blood Advances 2019, 3: 3278-3286. PMID: 31698456, PMCID: PMC6855099, DOI: 10.1182/bloodadvances.2019000569.
- Whole-Exome Sequencing in Evaluation of Thrombophilia: Characterization of Novel Genetic VariantsGu S, Shevell L, Tormey C, Rinder H, Lee A. Whole-Exome Sequencing in Evaluation of Thrombophilia: Characterization of Novel Genetic Variants. American Journal Of Clinical Pathology 2019, 152: s35-s35. DOI: 10.1093/ajcp/aqz112.066.
- Impact of a Pharmacist Driven Anti-Xa Level Monitoring Protocol on Therapeutic Drug Monitoring Practice PatternsEffendi M, Stutsky M, Curran C, Owusu K, Lee A. Impact of a Pharmacist Driven Anti-Xa Level Monitoring Protocol on Therapeutic Drug Monitoring Practice Patterns. Blood 2018, 132: 2284. DOI: 10.1182/blood-2018-99-119379.
- Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic PurpuraGoshua G, Gokhale A, Hendrickson J, Tormey C, Lee A. Cost Effectiveness of Rituximab As Adjunctive Therapy in Reducing Apheresis Procedures and Hospital Length of Stay in Relapsed Thrombotic Thrombocytopenic Purpura. Blood 2018, 132: 3814. DOI: 10.1182/blood-2018-99-113621.
- Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs AssessmentJuthani P, Ahmed D, Ahmed O, Bona R, Neparidze N, Lee A. Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs Assessment. Blood 2018, 132: 5810. DOI: 10.1182/blood-2018-99-119418.
- The Effects of Statin Therapy on Thrombus Resolution in Patients with Deep Venous ThrombosisHsu C, Brahmandam A, Brownson K, Huynh N, Reynolds J, Lee A, Fares W, Chaar C. The Effects of Statin Therapy on Thrombus Resolution in Patients with Deep Venous Thrombosis. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2018, 6: 291-292. DOI: 10.1016/j.jvsv.2017.12.034.
- Evaluation of Polycythemia: A Teachable MomentDjulbegovic M, Dugdale LS, Lee AI. Evaluation of Polycythemia: A Teachable Moment. JAMA Internal Medicine 2018, 178: 128-130. PMID: 29131894, DOI: 10.1001/jamainternmed.2017.6213.
- Anticoagulation for Proximal Deep Vein ThrombosisLee A, Lee E. Anticoagulation for Proximal Deep Vein Thrombosis. 2017, 299-313. DOI: 10.1007/978-3-319-65226-9_23.
- Whole-exome sequencing in evaluation of patients with venous thromboembolismLee EJ, Dykas DJ, Leavitt AD, Camire RM, Ebberink E, García de Frutos P, Gnanasambandan K, Gu SX, Huntington JA, Lentz SR, Mertens K, Parish CR, Rezaie AR, Sayeski PP, Cromwell C, Bar N, Halene S, Neparidze N, Parker TL, Burns AJ, Dumont A, Yao X, Chaar CIO, Connors JM, Bale AE, Lee AI. Whole-exome sequencing in evaluation of patients with venous thromboembolism. Blood Advances 2017, 1: 1224-1237. PMID: 29296762, PMCID: PMC5728544, DOI: 10.1182/bloodadvances.2017005249.
- A Novel Approach to the Medical Student Hematology CurriculumLevinsohn E, DiGiovanna M, Encandela J, Takizawa P, Hafler J, Lee A. A Novel Approach to the Medical Student Hematology Curriculum. Blood 2016, 128: 3537. DOI: 10.1182/blood.v128.22.3537.3537.
- Factors Influencing Hematology Career Choice in Hematology and Oncology Fellows at a Major Academic InstitutionWallace N, Hafler J, Hurwitz M, Podoltsev N, Lacy J, Lee A. Factors Influencing Hematology Career Choice in Hematology and Oncology Fellows at a Major Academic Institution. Blood 2016, 128: 3538. DOI: 10.1182/blood.v128.22.3538.3538.
- Thromboelastography in the Characterization of Coagulation Status in Antiphospholipid SyndromeWallace N, Dumont A, Burns A, Christopher T, Rinder H, Kriegel M, Buckley L, Erkan D, Lee A. Thromboelastography in the Characterization of Coagulation Status in Antiphospholipid Syndrome. Blood 2016, 128: 4983. DOI: 10.1182/blood.v128.22.4983.4983.
- The Hidden LesionLee AI, Chaar C. The Hidden Lesion. New England Journal Of Medicine 2016, 374: 2160-2165. PMID: 27248622, DOI: 10.1056/nejmcps1406615.
- Hemolysis Associated with IVIG TherapyRubin T, Lee A, Gehrie E, Hsu F. Hemolysis Associated with IVIG Therapy. Journal Of Allergy And Clinical Immunology 2016, 137: ab257. DOI: 10.1016/j.jaci.2015.12.928.
- Thrombus Resolution as Guide to Anticoagulation Therapy for Provoked Deep Vein Thrombosis: TRUDVT Pilot StudyBrownson K, Satoskar S, Reynolds J, Sumpio B, Sarac T, Scoutt L, Lee A. Thrombus Resolution as Guide to Anticoagulation Therapy for Provoked Deep Vein Thrombosis: TRUDVT Pilot Study. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2016, 4: 149. DOI: 10.1016/j.jvsv.2015.10.040.
- Clinical Practice Patterns of Anti-Xa Monitoring During Low Molecular Weight Heparin TherapyStutsky M, Reardon D, Lee A. Clinical Practice Patterns of Anti-Xa Monitoring During Low Molecular Weight Heparin Therapy. Blood 2015, 126: 3275. DOI: 10.1182/blood.v126.23.3275.3275.
- Whole Exome Sequencing in Evaluation of Thrombophilia: A Novel 33-Gene PanelLee E, Dykas D, Bale A, Cromwell C, Parker T, Halene S, Burns A, Yao X, Lee A. Whole Exome Sequencing in Evaluation of Thrombophilia: A Novel 33-Gene Panel. Blood 2015, 126: 3529. DOI: 10.1182/blood.v126.23.3529.3529.
- Patterns of Venous Thromboembolism Prophylaxis during Inpatient Treatment of Acute Leukemia: Results of a North American Web-Based SurveyLee E, Smith B, Merrey J, Lee A, Podoltsev N, Barbarotta L, Litzow M, Prebet T, Luger S, Gore S, Streiff M, Zeidan A. Patterns of Venous Thromboembolism Prophylaxis during Inpatient Treatment of Acute Leukemia: Results of a North American Web-Based Survey. Blood 2015, 126: 4455. DOI: 10.1182/blood.v126.23.4455.4455.
- North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute LeukemiaPine A, Lee E, Sekeres M, Steensma D, Prebet T, DeZern A, Komrokji R, Litzow M, Luger S, Stone R, Erba H, Garcia-Manero G, Lee A, Podoltsev N, Barbarotta L, Hendrickson J, Gore S, Zeidan A. North American Cooperative Group Members' Patterns of Blood Products Transfusion for Patients with Acute Leukemia. Blood 2015, 126: 1138. DOI: 10.1182/blood.v126.23.1138.1138.
- Characteristics of Provoked Deep Vein Thrombosis in a Tertiary Care CenterBrownson K, Brahmandam A, Huynh N, Reynolds J, Fares W, Stolar M, Lee A, Dardik A, Sarac T, Chaar C. Characteristics of Provoked Deep Vein Thrombosis in a Tertiary Care Center. Journal Of Vascular Surgery 2015, 62: 1095. DOI: 10.1016/j.jvs.2015.07.011.
- Is Pulmonary Embolism Predictable in Patients With Deep Vein Thrombosis?Huynh N, Fares W, Brownson K, Brahmandam A, Lee A, Dardik A, Sarac T, Chaar C. Is Pulmonary Embolism Predictable in Patients With Deep Vein Thrombosis? Journal Of Vascular Surgery 2015, 62: 806-807. DOI: 10.1016/j.jvs.2015.06.095.
- Profoundly Low Immunoglobulins, Lymphopenia, Thymoma and No InfectionsCatanzaro J, Lee A, Price C. Profoundly Low Immunoglobulins, Lymphopenia, Thymoma and No Infections. Journal Of Allergy And Clinical Immunology 2015, 135: ab15. DOI: 10.1016/j.jaci.2014.12.982.
- Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology UnitKim R, Yao X, Longley P, Rimar J, Kournioti C, Lee A. Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit. Blood 2014, 124: 1302. DOI: 10.1182/blood.v124.21.1302.1302.
- Venting the SpleenVarughese N, Duong A, Emre S, Xu M, Lee AI. Venting the Spleen. New England Journal Of Medicine 2013, 369: 1357-1363. PMID: 24088096, DOI: 10.1056/nejmcps1210943.
- Heparin-Induced Thrombocytopenia and Cardiac Surgery: A Role for Hematologists in Critical Care UnitsLee A, Sylvester K, Rawn J, Fanikos J, Berliner N. Heparin-Induced Thrombocytopenia and Cardiac Surgery: A Role for Hematologists in Critical Care Units. Blood 2011, 118: 2062. DOI: 10.1182/blood.v118.21.2062.2062.
- Clinical Significance of Coagulation Studies in Predicting Response to Recombinant Factor VIIa in Cardiac Surgery PatientsLee A, Campigotto F, Rawn J, Neuberg D, Kaufman R, Berliner N. Clinical Significance of Coagulation Studies in Predicting Response to Recombinant Factor VIIa in Cardiac Surgery Patients. Blood 2011, 118: 4351. DOI: 10.1182/blood.v118.21.4351.4351.
- A Bird's-Eye View of FeverLee AI, Koo S, Vaidya A, Katz JT, Loscalzo J. A Bird's-Eye View of Fever. New England Journal Of Medicine 2011, 365: 1727-1732. PMID: 22047564, DOI: 10.1056/nejmcps1012518.
- Treatment Choice and Outcome In Diffuse Large B Cell Lymphoma (DLBCL) Patients 75 Years and OlderToomey C, Muzikanksy A, Lee A, Barnes J, Michaelson J, Abramson J, Hochberg E. Treatment Choice and Outcome In Diffuse Large B Cell Lymphoma (DLBCL) Patients 75 Years and Older. Blood 2010, 116: 733. DOI: 10.1182/blood.v116.21.733.733.
- Rituximab Does Not Improve Progression Free (PFS) or Overall Survival (OS) in Patients with Limited Stage Diffuse Large B Cell Lymphoma (DLBCL).Hochberg E, Birrer N, Toomey C, Barnes J, Lee A, LaCasce A, Abramson J. Rituximab Does Not Improve Progression Free (PFS) or Overall Survival (OS) in Patients with Limited Stage Diffuse Large B Cell Lymphoma (DLBCL). Blood 2009, 114: 3755. DOI: 10.1182/blood.v114.22.3755.3755.
- Early Interim FDG-PET Scan Predicts Outcome in Non-Bulky Limited Stage Hodgkin Lymphoma, but may Not Guide Use of Consolidative Radiotherapy.Barnes J, LaCasce A, Toomey C, Hochberg E, Lee A, Canellos G, Abramson J. Early Interim FDG-PET Scan Predicts Outcome in Non-Bulky Limited Stage Hodgkin Lymphoma, but may Not Guide Use of Consolidative Radiotherapy. Blood 2008, 112: 1453. DOI: 10.1182/blood.v112.11.1453.1453.
- The RAG Proteins and V(D)J Recombination: Complexes, Ends, and TranspositionFugmann S, Lee A, Shockett P, Villey I, Schatz D. The RAG Proteins and V(D)J Recombination: Complexes, Ends, and Transposition. Annual Review Of Immunology 2000, 18: 495-527. PMID: 10837067, DOI: 10.1146/annurev.immunol.18.1.495.